Renal Safety Evaluation After Dotarem®-Enhanced MRI (RESCUE)

This is an interventional diagnostic trial for Renal Insufficiency focused on measuring contrast-induced nephropathy, creatinemia Read More

Inclusion Criteria:

• Male or female, > or equal 18 years ;
• Patient with a known stable renal insufficiency ;
• Patient scheduled to undergo an MRI examination to specify a diagnosis ;
• Patient able to understand and provide written informed consent to participate in the trial ;

Exclusion Criteria:

• Patient with a contra-indication to MRI ;
• Patient who has a diagnosis of an hemodynamic instability or acute myocardial infarction within 15 days prior the inclusion ;
• Patient who needs hemodialysis ;
• Patient with known allergy to gadolinium chelates ;
• Patient receiving medications known to be nephrotoxic or to cause increases in serum creatinine level within 2 weeks before the inclusion ;
• Patients planned to either undergo surgery or receive chemotherapy ;
• Any condition which, based on the investigator's clinical judgement, would prevent the patient from completing all trial assessments and visits ;
• Patient under guardianship and/or inability or unwillingness to cooperate with the requirements of this trial ;
• Patient with newly discovered unstable diabetes.